Get startedLog in
    Picture of Japan Tissue Engineering Co logo

    7774 — Japan Tissue Engineering Co Income Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Japan Tissue Engineering Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue2,3102,2582,1032,0322,514
    Cost of Revenue
    Gross Profit1,1881,1571,2551,1371,691
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses2,5452,7242,6032,7612,370
    Operating Profit-235-467-500-728145
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-230-463-494-725147
    Provision for Income Taxes
    Net Income After Taxes-287-467-498-729143
    Net Income Before Extraordinary Items
    Net Income-287-467-498-729143
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-287-467-498-729143
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-7.07-11.5-12.2-183.53
    Dividends per Share